Development and validation of a prognostic model for non-lung cancer death in elderly patients treated with stereotactic body radiotherapy for non-small cell lung cancer

This study sought to develop and validate a prognostic model for non-lung cancer death (NLCD) in elderly patients with non-small cell lung cancer (NSCLC) treated with stereotactic body radiotherapy (SBRT). Patients aged >= 65 diagnosed with NSCLC (Tis-4NOMO), tumor diameter = 2), 2.5 (CCI 1 or 2)...

Ausführliche Beschreibung